StemTek Therapeutics company
StemTek is a biopharmaceutical company focused on the research and development of drugs for cancer treatment. It utilizes stem cell centric point-of-view technologies for cancer therapy. It allows users to profile their pipeline of compounds for their effect on cancer stem cell populations, using 3D culture models. The company was founded in Angel Martin and Olatz Esnaola and is based in Bilbao, Spain.
%20.jpg)
Total Funding:
€50K
Headquarters:
Bilbao, Pais Vasco, Spain
Funding Status:
Seed
Employee Number:
1-10
Estimated Revenue:
Less than $1M
Last Funding Type:
Seed
Technology:
Regenerative Medicine
Investor Type:
For Profit
Investors Number:
2
Founded Date:
2013-01-01
Industry:
Biotechnology, Health Care, Science and Engineering